Adrenal Gland Cancer – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Adrenal Gland Cancer – Drugs In Development, 2024 report and make more profitable business decisions.
Adrenal gland cancer is a rare type of neuroendocrine tumor that originates from the cells of the adrenal glands, which are located on top of the kidneys. The adrenal glands produce hormones that regulate various functions in the body, such as blood pressure, metabolism, stress response, and sex drive. Adrenal gland cancer can affect the production of these hormones, causing symptoms such as weight gain, muscle weakness, high blood pressure, hair growth, and mood changes. Adrenal gland cancer can be benign or malignant. The most common malignant adrenal gland cancer is adrenocortical carcinoma, which starts in the outer layer of the adrenal glands. Adrenal gland cancer can be diagnosed with blood tests, urine tests, imaging tests, and biopsy. Treatment options include surgery, radiation therapy, chemotherapy, and targeted therapy.
The Adrenal Gland Cancer drugs in development market research report provide comprehensive information on the therapeutics under development for Adrenal Gland Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Adrenal Gland Cancer and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Adrenal Gland Cancer | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 43 molecules, with 38 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Adrenal Gland Cancer therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Adrenal Gland Cancer pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Adrenal Gland Cancer treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
ADC Therapeutics SAAdvanced Accelerator Applications SA
Agenus Inc
Aprea Therapeutics Inc
Ariceum Therapeutics GmbH
AstraZeneca Plc
Basilea Pharmaceutica International Ltd
Bristol-Myers Squibb Co
Chimerix Inc
Corcept Therapeutics Inc
Cytovation AS
Eisai Co Ltd
Enterome Bioscience SA
Exelixis Inc
Fukushima Medical University
Fusion Pharmaceuticals Inc
Gibson Oncology LLC
Infinity Pharmaceuticals Inc
Ipsen SA
Jubilant DraxImage Inc
Kyowa Kirin Co Ltd
Memorial Sloan Kettering Cancer Center
Merck & Co Inc
Merck KGaA
Orphagen Pharmaceuticals Inc
Osaka University
Perspective Therapeutics Inc
Pfizer Inc
Pharma Mar SA
Riboscience LLC
Sanofi
Shanghai Jiao Tong University School of Medicine
Sosei Group Corp
St. Jude Children’s Research Hospital Inc
Stcube Inc
Tempest Therapeutics Inc
Vyriad Inc
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Adrenal Gland Cancer reports